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Baeyer-Villiger oxidation under Payne epoxidation conditions 
Tyne Bradley, Andrei Dragan, and Nicholas Tomkinson 
WestCHEM, Department of Pure and Applied Chemistry, Thomas Graham Building, University of Strathclyde, 295 Cathedral Street, Glasgow, G1 1XL, U.K. 
 
Absract: A novel method for the Baeyer-Villiger oxidation of ketones has been developed and optimized. The transformation involves a transition metal-free 
activation of hydrogen peroxide under Payne epoxidation conditions. Reaction of a ketone with hydrogen peroxide in the presence of a nitrile under mildly basic 
reaction conditions leads to the corresponding ester. The transformation has been successfully applied to a range of ketones in moderate to excellent yields (30 
to 91%) and good to excellent regioselectivities (7:1 to 20:1). 
1. Introduction 
Since its discovery in 1899,1 the Baeyer-Villiger (BV) oxidation has developed to become a stalwart transformation in synthesis.2,3 
Central to the reaction is a source of peroxide, with meta-chloroperoxybenzoic acid (mCPBA) being a common commercial oxidant.4 A 
more convenient oxidant is hydrogen peroxide, due to its low cost, high oxygen content, ease of handling and the generation of water as 
a byproduct. Hydrogen peroxide is available either as an aqueous solution or in anhydrous form as a urea complex,5,6 or a sodium 
percarbonate salt,7±9 and each of these have found broad application in synthesis. 
For the BV reaction to proceed with hydrogen peroxide as the oxidant, the peroxide requires activation.3 Many activation methods 
involve the use of abundant Sn catalysts, the most efficient being Sn-zeolites.10±17 Other metals used for the activation of hydrogen 
peroxide in the BV oxidation include Se,18 Re,19 Li and Ca borates,20 Pt,21±23 Pd,24 Si polyoxometalates,25 and Zr.26 Metal-free methods 
also exist and make use of enzymes,27 ionic liquids,28 carboxylic acids,29 phosphoric acids,30,31 and bisflavins32 to activate the peroxide. 
Of these methods, a few have been shown to be effective for enantioselective BV oxidations, which include metals such as Pt, Pd or Zr 
with chiral ligands,21,24,26 pro-chiral carboxylic acids,29 phosphoric acids,30,31 and bisflavins.32 While there are a variety of methods of 
activating hydrogen peroxide, it is still desirable to develop methods to broaden the transformation, specifically by defining new 
pathways to potential asymmetric oxidations. 
A simple method using nitriles to activate hydrogen peroxide under mildly basic reaction conditions was introduced by Payne in 
1961 which resulted in an effective process for the epoxidation of alkenes (Scheme 1; Conditions A).33,34 Reaction of aqueous hydrogen 
peroxide (50%) with alkene 1 in the presence of benzonitrile at pH 9.5±10 gave the epoxide 2 in 70% isolated yield. This use of nitriles 
for the activation of hydrogen peroxide represents a convenient and simple reaction which has since been developed to provide an 
effective and reliable method for alkene oxidation,35±39 which has been extended to asymmetric epoxidations,40,41 and the formation of 
chiral oxaziridines.42,43 
Payne proposed the epoxidation proceeded via formation of a highly reactive peroxy imidic acid intermediate 3. Whilst there has 
been overwhelming acceptance of this suggestion, peroxy imidic acids are highly reactive and have not been isolated due to 
decomposition via Radziszewski oxidation leading to the corresponding amide.44 A study by Vacque et al. using attenuated total 
reflectance (ATR) coupled with Fourier transform infrared (FTIR) and FT Raman spectroscopy provided important experimental 
evidence toward the existence of such a peroxy imidic acid intermediate.45 
 
Scheme 1. Payne epoxidation. 
A recent report by Ji described the discovery of convenient and novel conditions for the Payne epoxidation of alkenes (Scheme 1; 
Conditions B).46 Treatment of an alkene (e.g. 1) with an excess of hydrogen peroxide urea complex in the presence of benzonitrile and 
potassium bicarbonate at 50 °C gave the epoxide 2 in 80% isolated yield after purification by column chromatography. Of particular 
note within this transformation was the practicality of the procedure using a convenient source of peroxide in the presence of a catalytic 
amount of base and the mild conditions under which the reaction proceeded. 
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Whilst a substantial amount of work has been devoted to the development of the Payne epoxidation, relatively little work has been 
undertaken in exploiting the oxidation potential of the peroxy imidic acid intermediates (e.g. 3) in alternative oxidation processes. This 
is specifically the case for the BV reaction where the isolated work of Ruiz investigated specialized heterogeneous magnesium,47 or 
magnesium/aluminum hydrotalcite supports as catalysts for the transformation.48,49 This work showed the reaction of a ketone (e.g. 4) in 
benzonitrile solvent with aqueous hydrogen peroxide, a heterogeneous catalyst and the surfactant DBS could lead to the corresponding 
ester or lactone (e.g. 5) (Scheme 2). Whilst effective, the need to prepare the catalyst through specific protocols and the use of 
benzonitrile as the solvent has limited the uptake of this method by the synthetic community. Within this current work we develop 
conditions for the activation of hydrogen peroxide with a nitrile which can be applied to the BV oxidation providing a convenient and 
reliable method for the preparation of both esters and lactones from the corresponding ketone. 
 
Scheme 2. Heterogeneous Baeyer-Villiger oxidation 
in benzonitrile. 
2. Results and discussion 
2.1. Initial result 
Our investigations began by the reaction of cyclohexanone 4 with urea hydrogen peroxide complex under conditions reported by Ji 
for alkene epoxidation (Scheme 3).46 We were delighted to discover that İ-caprolactone 5 was formed in 38% conversion by 1H NMR 
spectroscopy after 48 hours. Repeating the reaction in the absence of KHCO3, or H2O2·urea, or PhCN resulted in no product 5 being 
formed showing that all components added were necessary to bring about the transformation. 
 
Scheme 3. Baeyer-Villiger oxidation using benzonitrile 
for peroxide activation. 
2.2. Optimization of the Baeyer-Villiger reaction 
Based upon the excellent result outlined in Scheme 3, we elected to optimize the reaction conditions for this BV transformation. 
Table 1 provides a selection of the data obtained during this optimization process examining the concentration, base, peroxide source, 
solvent, reaction stoichiometry and temperature. 
To accelerate the optimization process initial experiments were conducted in methanol-d4 monitoring by 1H NMR spectroscopy and 
using 1,4-dinitrobenzene as an internal standard. Both increasing (entry 2; 30%) and decreasing (entry 3; 33%) the concentration of the 
reaction resulted in a lower conversion under the conditions examined. Reducing the temperature significantly slowed down the 
reaction (14%; entry 5), whilst performing the reaction at reflux had negligible effect on the conversion (44%; entry 6). Altering the 
peroxide source to H2O2 (30% v/v aqueous solution) resulted in a considerably worse transformation (31%; entry 9) suggesting that the 
urea hydrogen peroxide complex was an integral part of the process. Reducing the stoichiometry of both the nitrile (10%; entry 11) and 
the peroxide (25%; entry 7) also proved detrimental to the transformation. Increasing the amount of base resulted in an increased 
consumption of starting material, but this was accompanied by decomposition of the product as confirmed against the internal standard 
(entries 4 and 14). 
Careful examination of the crude reaction mixtures showed a small amount of the İ-caprolactone 5 was undergoing solvolysis with 
methanol to give the corresponding H-hydroxy ester. We therefore considered reducing the nucleophilicity of the alcoholic solvent to 
shut down this unwanted side reaction and investigated the use of fluorinated alcohols as the reaction medium. Interestingly, it has been 
shown that fluorinated alcohols can be used to accelerate reactions involving peroxides.50,51 It has also been shown that fluorinated 
alcohols have the ability to activate hydrogen peroxide,52 which has been specifically exploited in oxidation reactions. Examination of 
hexafluoroisopropanol (HFIP) as an alternative reaction solvent resulted in an equivalent conversion of cyclohexanone 4 to the ester 5 
(42%; entry 12). Importantly, within this transformation no reaction of 5 with the solvent was observed by 1H NMR spectroscopy. 
Changing the solvent to trifluoroethanol (TFE) showed a significantly improved conversion (76%; entry 13) which was confirmed by 
isolation of the product after aqueous workup and column chromatography (70%). Once again, control experiments in the absence of 
benzonitrile and/or base (KHCO3) confirmed that both were necessary for the reaction to proceed efficiently in TFE. 
Table 1. Optimization of the Baeyer-Villiger reaction produced via Scheme 3.a 












1 H2O2XUHD) 0.2 PhCN (6.0) MeOH (0.5) 50 38 
2 H2O2XUHD) 0.2 PhCN (6.0) CD3OD (1.0) 50 30 
3 H2O2XUHD) 0.2 PhCN (6.0) CD3OD (0.2) 50 33 
4 H2O2XUHD) 0.5 PhCN (6.0) CD3OD (0.5) 50 60c 
5 H2O2XUHD) 0.2 PhCN (6.0) CD3OD (0.5) 25 14 
6 H2O2XUHD) 0.2 PhCN (6.0) CD3OD (0.5) 65 44 
7 H2O2XUHD) 0.2 PhCN (6.0) CD3OD (0.5) 50 25 
8 H2O2XUHD) 0.2 PhCN (6.0) CD3OD (0.5) 50 47 
9 H2O2 30% (6.0) 0.2 PhCN (6.0) CD3OD (0.5) 50 31 
10 H2O2XUHD) 0.2 PhCN (3.0) CD3OD (0.5) 50 21 
11 H2O2XUHD) 0.2 PhCN (1.1) CD3OD (0.5) 50 10 
12 H2O2XUHD) 0.2 PhCN (6.0) HFIP (0.5) 50 42 
13 H2O2XUHD) 0.2 PhCN (6.0) TFE (0.5) 50 76 (70%)d 
14 H2O2XUHD.0) 0.5 PhCN (6.0) TFE (0.5) 50 95c 
15 H2O2XUHD.0) 0.1 PhCN (6.0) TFE (0.5) 50 37 
a
 Reaction of cyclohexanone (1 mmol) for 48 h. 
b
 Conversion was monitored by 1H NMR against an internal standard (1,4-dinitrobenzene). 
c
 Product decomposition observed. 
d




Table 2. Substrate scope for the Baeyer-Villiger oxidation. 
 
 
a Isolated yield. 
b Ratio between regioisomeric products (major isomer shown), determined by 1H NMR spectroscopy on crude reaction mixture. 
c
 Conversion to single product monitored by 1H NMR against an internal standard (1,4-dinitrobenzene). 
d
 Average of two runs. 
 
2.3. Substrate scope 
Having optimized the reaction conditions we examined some of the scope and limitations of the process (Table 2). The 
transformation exhibited typical features of the BV oxidation in terms of relative reactivity, regioselectivity and stereoselectivity. 
Reactions proceeded well and in good yield for a series of cyclohexanone derivatives (entries 1±9). Control of the regioselectivity was 
particularly high with more substituted groups preferentially migrating (entries 5±7 and 9). Increasing the steric congestion around the 
reactive carbonyl slowed down the reaction, but these transformations remained clean and simply required a longer reaction time 
(entries 6 and 9). Retention of configuration of the migrating carbon was supported by the optical rotation of the product derived from 
(±)-menthone 20 as the substrate (entry 9). Cyclopentanone 22 reacted slower (30%, 72 h; entry 10) when compared to cyclohexanone 4 
(70%, 48 h; entry 1), whereas cyclobutanone 24 reacted substantially quicker, giving the expected lactone in an excellent 85% yield in 
just 18 h (entry 11). Whilst acyclic ketones were reluctant substrates, it did prove possible to react pinacolone 28 to give the expected 
product 29 after extended reaction times (49%, 144 h; entry 13) suggesting further optimization would be required to bring about 
efficient transformations for this class of substrate. 
3. Conclusion 
In summary, a novel BV reaction has been developed and optimized. The transformation uses urea hydrogen peroxide complex as a 
convenient source of peroxide which is activated by benzonitrile and a catalytic amount of base (KHCO3) in a fluorinated alcohol to 
form the active peroxy imidic acid in situ. The reaction proceeds in moderate to good yields, with excellent and predictable 
regioselectivity and migration proceeding with retention of configuration. Given the marked success in developing asymmetric variants 
of the Payne epoxidation, we believe these results pave the way for exploring novel asymmetric BV oxidation processes. 
4. Experimental section 
4.1. General experimental details 
Commercially available solvents and reagents were used without further purification or drying and all reactions were performed 
under an argon atmosphere. Flash chromatography was carried out using Merck Kieselgel 60 H silica. Analytical thin layer 
chromatography was carried out using aluminum-backed plates coated with Merck Kieselgel 60 GF254 that were visualized under UV 
light (at 254 nm) or stained using KMnO4. Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker Avance III or a 
Bruker Avance spectrometer, operating at 400 MHz (1H) and 101 MHz (13C), respectively. Chemical shifts were reported in parts per 
million (ppm) in the scale relative to CHCl3, 7.26 ppm for 1H NMR and 77.16 for 13C NMR. Multiplicities are abbreviated as: s, singlet; 
d, doublet; app d, apparent doublet; t, triplet; app t, apparent triplet; q, quartet; dd, doublet of doublets; app dd, apparent doublet of 
doublets; app dq, apparent doublet of quartets; ddd, doublet of doublets of doublets; dtd, doublet of triplets of doublets; t app d, triplet 
of apparent doublets; m, multiplet. Coupling constants are measured in Hertz (Hz). Low-resolution mass spectra (LRMS) were recorded 
on an Agilent 7890A GC system, equipped with a 30 m DB5MS column connected to a 5975C inert XL CI MSD with Triple-Axis 
Detector. High-resolution mass spectra (HRMS) were obtained courtesy of the EPSRC National Mass Spectrometry Facility at Swansea 
University, U.K. Infrared spectra were recorded on a Shimadzu IRAffinity-1 equipped with ATR (Attenuated Total Reflectance) and 
were reported in cm±1. Melting points were obtained on a Stuart SMP11 device. In vacuo refers to evaporation under reduced pressure 
using a rotary evaporator connected to a diaphragm pump, followed by the removal of trace volatiles using a high vacuum (oil) pump. 
4.2. General Baeyer-Villiger procedure (General Procedure 1) 
To a flame dried crimp top vial under argon, KHCO3 (80 mg, 0.8 mmol, 0.2 equiv) was weighed, followed by urea hydrogen 
peroxide (564 mg, 24 mmol, 6.0 equiv). The ketone (4.0 mmol, 1.0 equiv) was added at this stage if it was a solid. The vial was then 
sealed and evacuated, followed by backfilling with argon (repeated three times). Afterward, the solvent (8.0 mL), benzonitrile (2.48 
mL, 24 mmol, 6.0 equiv) and, if it was a liquid, the ketone (4.0 mmol, 1.0 equiv), were added via syringe. The reaction was allowed to 
run for the specified time at 50 °C, after which it was cooled down to room temperature. The pressure was released with a needle, then 
the vial was opened. The mixture was diluted with CH2Cl2 (40 mL) and water (20 mL). The layers were separated and the resulting 
aqueous solution was extracted with CH2Cl2 (2 × 40 mL). The combined organic layers were dried (MgSO4), concentrated in vacuo, and 
the crude product was subjected to flash chromatography on silica gel (5:1 petroleum ether:EtOAc) to afford the corresponding 
product(s). 
4.3. İ-Caprolactone (5)53 
Lactone 5 was prepared according to General Procedure 1 using cyclohexanone 4 (0.44 mL, 4.0 mmol). The title compound was 
isolated as a colourless oil (321 mg, 2.8 mmol, 70%). 1H NMR (400 MHz, CDCl3į±4.17 (m, 2H), 2.71±2.57 (m, 2H), 1.90±1.80 
(m, 2H), 1.81±1.69 (m, 4H); 13C NMR (101 MHz, CDCl3 į 176.3, 69.4, 34.7, 29.4, 29.1, 23.1; LRMS (CI) m/z 115.0 [M+H]+; IR 
(ATR)/cm±1 2988, 2901, 1726. 
4.4. 5-Methyloxepan-2-one (7)54 
Lactone 7 was prepared according to General Procedure 1 using 4-methylcyclohexanone 6 (0.49 mL, 4.0 mmol). The title compound 
was isolated as a colourless oil (421 mg, 3.3 mmol, 82%). 1H NMR (400 MHz, CDCl3įGGGJ = 12.9, 5.7, 1.9 Hz, 1H), 4.17 (dd, 
J = 12.7, 10.4 Hz, 1H), 2.71±2.56 (m, 2H), 1.98±1.83 (m, 2H), 1.82±1.71 (m, 1H), 1.50 (dtd, J = 15.2, 10.8, 1.8 Hz, 1H), 1.33 (dtd, J = 
13.9, 11.5, 2.4 Hz, 1H), 0.99 (d, J = 6.6 Hz, 3H); 13C NMR (101 MHz, CDCl3į 176.3, 68.3, 37.4, 35.4, 33.4, 30.9, 22.3; LRMS (CI) 
m/z 129.0 [M+H]+; HRMS (SIR-CI) calculated for C7H13O2 [M+H]+ 129.0910, found 129.0910; IR (ATR)/cm±1 2988, 2901, 1717. 
4.5. 5-(tert-Butyl)oxepan-2-one (9)55 
Lactone 9 was prepared according to General Procedure 1 using 4-tert-butylcyclohexanone 8 (617 mg, 4.0 mmol). The title 
compound was isolated as a white solid (554 mg, 3.3 mmol, 81%). m.p. 49±50 °C (lit. 49 °C);55 1H NMR (400 MHz, CDCl3į
(ddd, J = 12.9, 5.9, 1.8 Hz, 1H), 4.14 (dd, J = 12.9, 10.4 Hz, 1H), 2.69 (ddd, J = 14.3, 7.5, 1.4 Hz, 1H), 2.61±2.51 (m, 1H), 2.13±1.95 
(m, 2H), 1.58±1.44 (m, 1H), 1.38±1.28 (m, 2H), 0.88 (s, 9H); 13C NMR (101 MHz, CDCl3) į 176.5, 68.8, 50.9, 33.6, 33.1, 30.5, 27.6, 
23.9; LRMS (CI) m/z 171.1 [M+H]+; HRMS (FTMS-NSI) calculated for C10H19O2 [M+H]+ 171.1380, found 171.1377; IR (ATR)/cm±1 
2987, 2961, 1717. 
4.6. 5-Phenyloxepan-2-one (11)56 
Lactone 11 was prepared according to General Procedure 1 using 4-phenylcyclohexanone 10 (697 mg, 4.0 mmol). The title 
compound was isolated as a white solid (629 mg, 3.3 mmol, 83%). m.p. 95±96 °C (lit. 100±101 °C);56 1H NMR (400 MHz, CDCl3į
7.36±7.29 (m, 2H), 7.26±7.21 (m, 1H), 7.21±7.16 (m, 2H), 4.40 (ddd, J = 13.0, 5.3, 2.3 Hz, 1H), 4.32 (ddd, J = 13.0, 10.0, 1.0 Hz, 1H), 
2.90±2.71 (m, 3H), 2.20±1.98 (m, 3H), 1.91±1.80 (m, 1H); 13C NMR (101 MHz, CDCl3) į 176.0, 145.1, 128.9, 127.0, 126.7, 68.4, 47.4, 
36.9, 33.8, 30.5; LRMS (CI) m/z 191.1 [M+H]+; HRMS (FTMS-NSI) calculated for C12H15O2 [M+H]+ 191.1067, found 191.1064; IR 
(ATR)/cm±1 2960, 2943, 1740. 
4.7. 7-Methyloxepan-2-one (13)53 
Lactone 13 was prepared as a 7:1 mixture of regioisomers, according to General Procedure 1 using 2-methylcyclohexanone 12 (0.49 
mL, 4.0 mmol). The title compound was isolated after column chromatography as a colourless oil (468 mg, 3.7 mmol, 91%, 15:1 
mixture of regioisomers). 1H NMR (400 MHz, CDCl3įapp dq, J = 8.3, 6.4 Hz, 1H major), 4.31±4.15 (m, 2H minor), 2.72±2.52 
 6 
(m, 2H major, 1H minor), 1.99±1.83 (m, 3H major, 2H minor), 1.72±1.51 (m, 3H major, 4H minor), 1.34 (d, J = 6.4 Hz, 3H major), 
1.18 (d, J = 6.7 Hz, 3H minor); 13C NMR (101 MHz, CDCl3, major isomerį 175.7, 76.9, 36.4, 35.1, 28.4, 23.0, 22.7; LRMS (CI) m/z 
129.0 [M+H]+; IR (ATR)/cm±1 2987, 2901, 1716. 
4.8. 7-Ethyloxepan-2-one (15)57 
Lactone 15 was prepared as a 15:1 mixture of regioisomers, according to General Procedure 1 using 2-ethylcyclohexanone 14 (0.56 
mL, 4.0 mmol). The title compound was isolated after column chromatography as a colourless oil (410 mg, 2.9 mmol, 72%, 12:1 
mixture of regioisomers). 1H NMR (400 MHz, CDCl3į±4.24 (m, 2H minor), 4.16 (t app d, J = 7.8, 5.3 Hz, 1H major), 2.71±2.54 
(m, 2H major), 2.49±2.39 (m, 1H minor) , 2.03±1.84 (m, 3H major, 2H minor), 1.80±1.67 (m, 1H major, 2H minor), 1.66±1.51 (m, 4H 
major, 2H minor), 1.47±1.37 (m, 2H minor) 0.98 (t, J = 7.4 Hz, 3H major), 0.95 (t, J = 7.6 Hz, 3H minor); 13C NMR (101 MHz, CDCl3, PDMRULVRPHUį 34.3, 29.5, 28.5, 23.2, 10.0; LRMS (CI) m/z 143.1 [M+H]+; HRMS (TOF-EI) calculated for C8H14O2 >0@IRXQG,5$75FP±1 2970, 2931, 1721. 
4.9. 7-Phenyloxepan-2-one (17)58 
Lactone 17 was prepared as a 20:1 mixture of regioisomers, according to General Procedure 1 using 2-phenylcyclohexanone 16 (697 
mg, 4.0 mmol). The title compound was isolated after column chromatography as a white solid (683 mg, 3.6 mmol, 90%, 20:1 mixture 
of regioisomers). m.p. 68±69 °C (lit. 67±68 °C);58 1H NMR (400 MHz, CDCl3į60±7.21 (m, 5H major, 5H minor), 5.29 (app d, J = 
9.4 Hz, 1H major), 4.40±4.35 (m, 2H minor), 3.91±3.86 (m, 1H minor), 2.77 (dd, J = 7.7, 3.7 Hz, 2H major), 2.18±1.97 (m, 4H major, 
4H minor), 1.84±1.64 (m, 2H major, 2H minor); 13C NMR (101 MHz, CDCl3) į 175.0, 140.9, 128.7, 128.3, 126.0, 82.3, 37.6, 35.1, 
28.8, 23.0; LRMS (CI) m/z 191.1 [M+H]+; HRMS (FTMS-NSI) calculated for C12H15O2 [M+H]+ 191.1067, found 191.1063; IR 
(ATR)/cm±1 2928, 2868, 1717. 
4.10. 1,4,8-Trioxaspiro[4.6]undecan-9-one (19) 
Lactone 19 was prepared according to General Procedure 1 using 1,4-dioxaspiro[4.5]decan-8-one 18 (625 mg, 4.0 mmol). The title 
compound was isolated as a colourless oil (244 mg, 1.4 mmol, 36%). 1H NMR (400 MHz, CDCl3į8±4.19 (m, 2H), 3.96±3.91 (m, 
4H), 2.70±2.60 (m, 2H), 2.00±1.92 (m, 2H), 1.91±1.81 (m, 2H); 13C NMR (101 MHz, CDCl3) į 175.5, 107.8, 64.8, 64.3, 39.0, 32.7, 
28.8; LRMS (CI) m/z 173.1 [M+H]+; HRMS (FTMS-NSI) calculated for C8H13O4 [M+H]+ 173.0808, found 173.0804; IR (ATR)/cm±1 
2970, 2889, 1729. 
4.11. (4R,7S)-7-Isopropyl-4-methyloxepan-2-one (21)59 
Lactone 21 was prepared according to General Procedure 1 using (±)-menthone 20 (0.69 mL, 4.0 mmol). The title compound was 
isolated as a colourless oil (344 mg, 2.0 mmol, 51%).  ሾDሿୈଶ଴ ±20.6 (c 0.72, CHCl3), lit. ±19.7;59 1H NMR (400 MHz, CDCl3įapp dd, J = 9.2, 4.5 Hz, 1H), 2.65±2.39 (m, 2H), 2.03±
1.77 (m, 4H), 1.66±1.52 (m, 1H), 1.35±1.21 (m, 1H), 1.03 (d, J = 6.7 Hz, 3H), 0.97 (d, J = 6.8 Hz, 3H), 0.96 (d, J = 6.8 Hz, 3H); 13C 
NMR (101 MHz, CDCl3 į 175.1, 84.9, 42.7, 37.6, 33.5, 31.1, 30.5, 24.1, 18.5, 17.3; LRMS (CI) m/z 171.1 [M+H]+; HRMS 
(FTMS-NSI) calculated for C10H19O2 [M+H]+ 171.1380, found 171.1376; IR (ATR)/cm±1 2970, 2928, 1722. 
4.12. Tetrahydro-2H-pyran-2-one (23)60 
Lactone 23 was prepared according to General Procedure 1 using cyclopentanone 22 (0.36 mL, 4.0 mmol). The title compound was 
isolated as a colourless oil (118 mg, 1.1 mmol, 30%). 1H NMR (400 MHz, CDCl3į±4.29 (m, 2H), 2.54 (t, J = 7.1 Hz, 2H), 1.97±
1.78 (m, 4H); 13C NMR (101 MHz, CDCl3į171.5, 69.5, 29.9, 22.4, 19.2; LRMS (CI) m/z 104.0 [M+H]+; IR (ATR)/cm±1 2970, 2934, 
1724. 
4.13. Dihydrofuran-2(3H)-one (25)60 
Lactone 25 was prepared according to General Procedure 1 using cyclobutanone 24 (0.30 mL, 4.0 mmol). The title compound was 
isolated as a colourless oil (292 mg, 3.4 mmol, 85%). 1H NMR (400 MHz, CDCl3įWJ = 7.0 Hz, 2H), 2.57±2.44 (m, 2H), 2.35±
2.18 (m, 2H); 13C NMR (101 MHz, CDCl3į 177.8, 68.6, 27.9, 22.3; LRMS (CI) m/z 87.0 [M+H]+; IR (ATR)/cm±1 2988, 2901, 1763. 
4.14. Rel-(1R,3R,6S,8S)-4-Oxatricyclo[4.3.1.13,8]undecan-5-one (27)61 
Lactone 27 was prepared according to General Procedure 1 using 2-adamantanone 26 (600 mg, 4.0 mmol). The title compound was 
isolated as a white solid (545 mg, 3.3 mmol, 82%). m.p. >250 °C (lit. 288±290 °C);61 1H NMR (400 MHz, CDCl3į4.51±4.43 (m, 1H), 
3.06 (app t, J = 5.8 Hz, 1H), 2.14±1.88 (m, 8H), 1.86±1.78 (m, 2H), 1.77±1.70 (m, 2H); 13C NMR (101 MHz, CDCl3į 179.1, 73.3, 
41.4, 35.9, 33.9, 31.1, 26.0; LRMS (CI) m/z 167.0 [M+H]+; HRMS (FTMS-NSI) calculated for C10H15O2 [M+H]+ 167.1067, found 
167.1063; IR (ATR)/cm±1 2988, 2911, 1717. 
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